APC and Familial adenomatous polyposis: The occurrence of somatic APC gene mutations in FAP patients on the other hand, could serve as a potential source of therapeutic peptides that may delay the onset of, or prevent CRC development, through immune vigilance mechanisms over the life of an affected individual.